Literature DB >> 16933027

Exercise prescription and thrombogenesis.

Jong-Shyan Wang1.   

Abstract

Lifestyle habits, such as exercise, may significantly influence risk of major vascular thrombotic events. The risk of primary cardiac arrest has been shown to transiently increase during vigorous exercise, whereas regular moderate-intensity exercise is associated with an overall reduced risk of cardiovascular diseases. What are the mechanisms underlying these paradoxical effects of vigorous exercise versus exercise training on thrombotic modification? This review analyzes research regarding effects and their underlying mechanisms of acute exercise, endurance training, and deconditioning on platelets, coagulation, and fibrinolysis. Evidence suggests that (i) light, acute exercise ( < or = 49% VO(2 max)) does not affect platelet reactivity and coagulation and increases fibrinolytic activity; (ii) moderate, acute exercise (50 to approximately 74% VO(2 max)) suppresses platelet reactivity and enhances fibrinolysis, which remains unchanged in the coagulation system; and, (iii) strenuous, acute exercise ( > or = 75% VO(2 max)) enhances both platelet reactivity and coagulation, simultaneously promoting fibrinolytic activity. Therefore, moderate exercise is likely a safe and effective exercise dosage for minimizing risk of cardiovascular diseases by inducing beneficial anti-thrombotic changes. Moreover, moderate-intensity exercise training reduces platelet reactivity and enhances fibrinolysis at rest, also attenuating enhanced platelet reactivity and augmenting hyper-fibrinolytic activity during strenuous exercise. However, these favorable effects of exercise training on thrombotic modification return to a pre-training state after a period of deconditioning. These findings can aid in determining appropriate exercise regimes to prevent early thrombotic events and further hinder the cardiovascular disease progression.

Entities:  

Mesh:

Year:  2006        PMID: 16933027     DOI: 10.1007/s11373-006-9105-7

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  7 in total

1.  Exercise affects platelet-promoted tumor cell adhesion and invasion to endothelium.

Authors:  Yu-Wen Chen; Jan-Kan Chen; Jong-Shyan Wang
Journal:  Eur J Appl Physiol       Date:  2008-11-08       Impact factor: 3.078

2.  Functional status and inflammation after preseason training program in professional and recreational soccer players: a proteomic approach.

Authors:  Francisco J Martín-Sánchez; José María Villalón; José J Zamorano-León; Luis Fernández Rosas; Ricardo Proietti; Petra J Mateos-Caceres; Juan J González-Armengol; Pedro Villarroel; Carlos Macaya; Antonio J López-Farré
Journal:  J Sports Sci Med       Date:  2011-03-01       Impact factor: 2.988

3.  Endurance training modifies exercise-induced activation of blood coagulation: RCT.

Authors:  Thomas Hilberg; Kathleen Menzel; Udo F Wehmeier
Journal:  Eur J Appl Physiol       Date:  2012-12-13       Impact factor: 3.078

4.  High-intensity Interval Training Improves Mitochondrial Function and Suppresses Thrombin Generation in Platelets undergoing Hypoxic Stress.

Authors:  Li-Hua Wu; Shao-Chiang Chang; Tieh-Cheng Fu; Ching-Hui Huang; Jong-Shyan Wang
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

5.  Training-induced changes in clotting parameters of athletic horses.

Authors:  Giuseppe Piccione; Marilena Bazzano; Claudia Giannetto; Simona Marafioti; Francesco Fazio
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

6.  Moderate Exercise Attenuates Lipopolysaccharide-Induced Inflammation and Associated Maternal and Fetal Morbidities in Pregnant Rats.

Authors:  Karina T Kasawara; Tiziana Cotechini; Shannyn K Macdonald-Goodfellow; Fernanda G Surita; João L Pinto E Silva; Chandrakant Tayade; Maha Othman; Terence R S Ozolinš; Charles H Graham
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

7.  Exercise Training Enhances Platelet Mitochondrial Bioenergetics in Stroke Patients: A Randomized Controlled Trial.

Authors:  Chih-Chin Hsu; Hsing-Hua Tsai; Tieh-Cheng Fu; Jong-Shyan Wang
Journal:  J Clin Med       Date:  2019-12-11       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.